ESC 365 - Serum cholinesterase level provides the additional long-time prognostic information over AHEAD risk score in patients with acute decompensated heart failure with preserved ejection fraction.

ESC Professional Premium Access

Serum cholinesterase level provides the additional long-time prognostic information over AHEAD risk score in patients with acute decompensated heart failure with preserved ejection fraction.

Session: Novel biomarkers in heart failure

Topic: Biomarkers

Speaker: Doctor T. Kondo (Osaka, JP)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Takumi Kondo

Osaka General Medical Center, Osaka (Japan)

0 follower

5 more presentations in this session

Association of CA-125 with markers of congestion, and effect of empagliflozin on CA-125 in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF)

Speaker: Doctor M. Lee (Glasgow, GB)

Circulating amyloid-beta 1-40 levels associate with cardiac remodelling and myocardial recovery in advanced heart failure

Speaker: Doctor K. Sopova (Mannheim, DE)

Selenium deficiency is associated with anemia in heart failure patients - The HARVEST Study

Speaker: Doctor J. Molvin (Malmoe, SE)

Fractional excretion of urea nitrogen can identify true worsening renal function in patients with acute heart failure

Speaker: Doctor Y. Watanabe (Tokyo, JP)

Meteorin-like plasma levels as a novel biomarker for heart failure

Speaker: Ms L. Anido Varela (Santiago de Compostela, ES)

Access the full session

Novel biomarkers in heart failure

Speakers: Doctor T. Kondo, Doctor M. Lee, Doctor K. Sopova, Doctor J. Molvin, Doctor Y. Watanabe...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources